Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol CIDEB contributors: mct - updated : 08-04-2015
HGNC name cell death-inducing DFFA-like effector b
HGNC id 1977
DNA
TYPE functioning gene
STRUCTURE 6.19 kb     7 Exon(s)
10 Kb 5' upstream gene genomic sequence study
regulatory sequence Promoter
Binding site
text structure expression driven by two promoters which are responsible for the synthesis of two types of transcript, and Sp1 and Sp3 are key regulators of basal transcription from both the upstream and the internal promoter
MAPPING cloned Y linked   status provisional
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
7 - 2252 26 219 - 2013 24161736
EXPRESSION
Type widely
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Digestiveintestinesmall intestinejejunum highly Homo sapiens
 intestinesmall intestineileum highly Homo sapiens
 liver   highly Homo sapiens
Endocrinepancreas   highly Homo sapiens
cells
SystemCellPubmedSpeciesStageRna symbol
Digestivehepatocyte Homo sapiens
Endocrineislet cell (alpha,beta...) Homo sapiens
cell lineage
cell lines
fluid/secretion
at STAGE
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • a CIDE-N domain
  • strong cell death-inducing activity in its C-terminal domain
  • HOMOLOGY
    Homologene
    FAMILY cell death-inducing DFF45-like effector (CIDE) protein family
    CATEGORY regulatory
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm,organelle,endoplasmic reticulum
    intracellular,cytoplasm,organelle,Golgi
    intracellular,cytoplasm,cytosolic
    text
  • localization to endoplasmic reticulum (ER) and lipid droplets (LD), and also localized to the Golgi apparatus
  • basic FUNCTION
  • cell death-inducing DFFA-like effector B
  • putatively involved in apoptotic DNA fragmentation
  • inducing cell death in a caspase-dependent manner through cytochrome c release from mitochondria
  • important regulator in the development of obesity and diabetes by controlling fatty acid synthesis and VLDL secretion in hepatocytes
  • is a novel regulator in controlling cholesterol homeostasis in the liver
  • present in pancreatic beta-cells and involved in palmitate induced beta-cell apoptosis
  • CIDEB and PLIN2 play opposing roles in controlling VLDL lipidation and hepatic lipid homeostasis
  • direct requirement of CIDEB in VTV (very low density lipoprotein (VLDL) transport vesicle) formation
  • potential role in VLDL transport from the ER to the Golgi
  • mediates lipid droplet (LD) fusion, as well as very-low-density lipoprotein (VLDL) maturation
  • play a critical role in maintaining hepatic lipid homeostasis by promoting the lipidation and maturation of VLDL particles
  • plays an important role in controlling intestinal chylomicron lipidation
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • DFFA/DFFB complex
  • PPARGC1A plays an important role in partitioning cytoplasmic Triglycerdes toward the VLDL secretory compartments and promoting VLDL secretion via transcriptional induction of CIDEB
  • interacts with APOB100 in the ER, whereas it does not interact with albumin, which is excluded from the VTV
  • CIDEB is an essential cofactor for hepatitis C virus (HCV) entry into hepatocytes
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    diabetemetabolic syndrom 
    could serve as an important therapeutical target for the treatment of atherosclerosis and cardiovascular diseases
    ANIMAL & CELL MODELS
  • mice with Cideb deficiency exhibited reduced intestinal chylomicron-TG secretion and increased lipid accumulation in the enterocytes